| Heart rate variability in epilepsy: a potential biomarker of sudden unexpected death in epilepsy risk KA Myers, LE Bello‐Espinosa, JD Symonds, SM Zuberi, R Clegg, ... Epilepsia 59 (7), 1372-1380, 2018 | 145 | 2018 |
| The genetic landscape of epilepsy of infancy with migrating focal seizures R Burgess, S Wang, A McTague, KE Boysen, X Yang, Q Zeng, KA Myers, ... Annals of neurology 86 (6), 821-831, 2019 | 135 | 2019 |
| Epilepsy genetics: current knowledge, applications, and future directions KA Myers, DL Johnstone, DA Dyment Clinical genetics 95 (1), 95-111, 2019 | 126 | 2019 |
| Osteoblast-like cells and fluid flow: cytoskeleton-dependent shear sensitivity KA Myers, JB Rattner, NG Shrive, DA Hart Biochemical and biophysical research communications 364 (2), 214-219, 2007 | 110 | 2007 |
| Heart rate variability measurement in epilepsy: How can we move from research to clinical practice? KA Myers, S Sivathamboo, P Perucca Epilepsia 59 (12), 2169-2178, 2018 | 105 | 2018 |
| Hydrostatic pressure sensation in cells: integration into the tensegrity model KA Myers, JB Rattner, NG Shrive, DA Hart Biochemistry and cell biology 85 (5), 543-551, 2007 | 80 | 2007 |
| Genetic literacy series: genetic epilepsy with febrile seizures plus KA Myers, IE Scheffer, SF Berkovic, ILAE Genetics Commission Epileptic Disorders 20 (4), 232-238, 2018 | 79 | 2018 |
| KCNT1‐related epilepsy: An international multicenter cohort of 27 pediatric cases F Borlot, A Abushama, N Morrison‐Levy, P Jain, K Puthenveettil Vinayan, ... Epilepsia 61 (4), 679-692, 2020 | 72 | 2020 |
| Stiripentol efficacy and safety in Dravet syndrome: a 12‐year observational study KA Myers, P Lightfoot, SG Patil, JH Cross, IE Scheffer Developmental Medicine & Child Neurology 60 (6), 574-578, 2018 | 72 | 2018 |
| Clinical utility of multigene panel testing in adults with epilepsy and intellectual disability F Borlot, BI de Almeida, SL Combe, DM Andrade, FM Filloux, KA Myers Epilepsia 60 (8), 1661-1669, 2019 | 59 | 2019 |
| Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency KA Myers, A Nikolic, K Romanchuk, E Weis, MA Brundler, L Lafay-Cousin, ... Neuro-Oncology Practice 4 (1), 60-66, 2017 | 58 | 2017 |
| GRIN2A-related speech disorders and epilepsy KA Myers, IE Scheffer | 51 | 2016 |
| De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome KA Myers, R Burgess, Z Afawi, JA Damiano, SF Berkovic, MS Hildebrand, ... Epilepsia 58 (2), e26-e30, 2017 | 50 | 2017 |
| Whole‐exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation S Venkateswaran, KA Myers, AC Smith, CL Beaulieu, ... Epilepsia 55 (7), e75-e79, 2014 | 49 | 2014 |
| DEPDC5 as a potential therapeutic target for epilepsy KA Myers, IE Scheffer Expert opinion on therapeutic targets 21 (6), 591-600, 2017 | 43 | 2017 |
| Hydrostatic pressure stimulation of human mesenchymal stem cells seeded on collagen-based artificial extracellular matrices R Hess, T Douglas, KA Myers, B Rentsch, C Rentsch, H Worch, NG Shrive, ... | 43 | 2010 |
| ADGRV1 is implicated in myoclonic epilepsy KA Myers, S Nasioulas, A Boys, JM McMahon, H Slater, P Lockhart, ... Epilepsia 59 (2), 381-388, 2018 | 40 | 2018 |
| Fatal cerebral edema with status epilepticus in children with Dravet syndrome: report of 5 cases KA Myers, JM McMahon, SA Mandelstam, MT Mackay, RM Kalnins, ... Pediatrics 139 (4), 2017 | 37 | 2017 |
| Systematic review of MRI findings in children with developmental delay or cognitive impairment K Murias, A Moir, KA Myers, I Liu, XC Wei Brain and Development 39 (8), 644-655, 2017 | 36 | 2017 |
| TUBA1A mutation associated with eye abnormalities in addition to brain malformation KA Myers, LE Bello-Espinosa, A Kherani, XC Wei, AM Innes Pediatric neurology 53 (5), 442-444, 2015 | 34 | 2015 |
David DymentDepartment of Genetics; Children's Hospital of Eastern OntarioVerified email at cheo.on.ca